Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (175) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position (3) Apply CMDh final position filter Opinion provided by Committee for Medicinal Products for Human Use (3) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (12) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 20 procedures Remove Article 20 procedures filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 13 referrals Remove Article 13 referrals filter Article 107i procedures Remove Article 107i procedures filter Article 31 referrals (105) Apply Article 31 referrals filter Article 30 referrals (94) Apply Article 30 referrals filter Article 35 (45) Apply Article 35 filter Article 33 (43) Apply Article 33 filter Article 34 (20) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 13 (6) Apply Article 13 filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 78 (5) Apply Article 78 filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter PRAC-CHMP-EC (18) Apply PRAC-CHMP-EC filter PRAC-CMDh (5) Apply PRAC-CMDh filter

Referral authorisation model

Centrally authorised product(s) (22) Apply Centrally authorised product(s) filter Nationally authorised product(s) (18) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

No further action (1) Apply No further action filter Risk minimisation measures (17) Apply Risk minimisation measures filter Suspension (4) Apply Suspension filter Variation (2) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (10) Apply Additional monitoring filter Conditional approval (2) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

175 results

Remove all filtersRemove all filters

Referral type Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 20 procedures Remove Article 20 procedures filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 13 referrals Remove Article 13 referrals filter Article 107i procedures Remove Article 107i procedures filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter

Sort by

List item

Referral: Alcover and associated names

sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018
List item

Referral: Zinbryta

daclizumab, associated names: Zinbryta, Article 20 procedures
Status: European Commission final decision, opinion/position date: 09/11/2017, EC decision date: 08/01/2018, Last updated: 12/01/2018
List item

Referral: Paracetamol/Ibuprofen 500 mg/150 mg film-coated tablets

paracetamol, ibuprofen, associated names: Paracomb, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/05/2017, EC decision date: 07/08/2017, Last updated: 18/08/2017
List item

Referral: Cardioxane

dexrazoxane, Article 13 referrals
Status: European Commission final decision, opinion/position date: 19/07/2017, EC decision date: 19/07/2017, Last updated: 26/07/2017
List item

Referral: SGLT2 inhibitors (previously canagliflozin)

canagliflozin, empagliflozin, dapagliflozin, metformin, associated names: Xigduo, Ebymect, Edistride, Synjardy, Forxiga, Jardiance, Vokanamet, Invokana, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 04/05/2017, Last updated: 08/05/2017
List item

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

daclatasvir, dasabuvir, sofosbuvir, ledipasvir, simeprevir, ombitasvir, paritaprevir, ritonavir, associated names: Sovaldi, Olysio, Viekirax, Harvoni, Exviera, Daklinza, Article 20 procedures
Status: European Commission final decision, opinion/position date: 15/12/2016, EC decision date: 23/02/2017, Last updated: 09/03/2017
List item

Referral: Diclofenac epolamine 50 mg tablets

diclofenac, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 22/09/2016, Last updated: 10/10/2016
List item

Referral: Zydelig

idelalisib, associated names: Zydelig, Article 20 procedures
Status: European Commission final decision, opinion/position date: 21/07/2016, EC decision date: 15/09/2016, Last updated: 03/10/2016
List item

Referral: Levonelle 1500 microgram tablets and associated names

levonorgestrel, Article 13 referrals
Status: European Commission final decision, opinion/position date: 26/05/2016, EC decision date: 01/08/2016, Last updated: 09/08/2016
List item

Referral: SGLT2 inhibitors

canagliflozin, dapagliflozin, empagliflozin, associated names: Edistride, Ebymect, Xigduo, Vokanamet, Synjardy, Jardiance, Invokana, Forxiga, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 28/04/2016, Last updated: 18/05/2016
List item

Referral: Tysabri

natalizumab, associated names: Tysabri, Article 20 procedures
Status: European Commission final decision, opinion/position date: 25/02/2016, EC decision date: 25/04/2016, Last updated: 12/05/2016
List item

Referral: Tobramycin VVB and associated names

tobramycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/01/2015, EC decision date: 04/04/2016, Last updated: 04/05/2016
List item

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

bivalent HPV vaccine (types 16, 18), quadrivalent HPV vaccine (types 6, 11, 16, 18), 9-valent HPV vaccine (types 6, 11, 16, 18, 31, 33, 45, 52 and 58), associated names: Cervarix, Gardasil, Gardasil 9, Silgard, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/11/2015, EC decision date: 12/01/2016, Last updated: 20/01/2016
List item

Referral: Inductos

dibotermin alfa, associated names: Inductos, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/10/2015, EC decision date: 20/11/2015, Last updated: 07/12/2015
List item

Referral: Merisone and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015
List item

Referral: Myoson and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, Last updated: 28/07/2015
List item

Referral: Iclusig

ponatinib, Article 20 procedures
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 15/01/2015, Last updated: 02/03/2015
List item

Referral: Corlentor and Procoralan

ivabradine, associated names: Corlentor and Procoralan, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 15/01/2015, Last updated: 16/02/2015
List item

Referral: Seasonique and associated names

levonorgestrel, ethinylestradiol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/11/2014, EC decision date: 12/01/2015, Last updated: 29/01/2015
List item

Referral: Oxynal Targin and associated names

oxycodone hydrochloride, naloxone hydrochloride, Article 13 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 22/12/2014, Last updated: 27/01/2015
List item

Referral: Protelos and Osseor

strontium ranelate, Article 20 procedures
Status: European Commission final decision, opinion/position date: 20/02/2014, EC decision date: 15/04/2014, Last updated: 18/09/2014
List item

Referral: Dexamed and associated names

dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 02/09/2014
List item

Referral: Nanotop and associated names

human albumin, denatured, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 28/02/2014, Last updated: 16/06/2014
List item

Referral: Kogenate Bayer and Helixate NexGen

octocog alfa, Article 20 procedures
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 20/02/2014, Last updated: 09/04/2014
List item

Referral: Tibolona Aristo and Tibocina and associated names

tibolone, associated names: Tibolon Aristo, Tibolinia, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 05/03/2014, Last updated: 08/04/2014

Load more

175 results

Referral: Alcover and associated names

Referral: Zinbryta

Referral: Paracetamol/Ibuprofen 500 mg/150 mg film-coated tablets

Referral: Cardioxane

Referral: SGLT2 inhibitors (previously canagliflozin)

Referral: Direct-acting antivirals indicated for treatment of hepatitis C (interferon-free)

Referral: Diclofenac epolamine 50 mg tablets

Referral: Zydelig

Referral: Levonelle 1500 microgram tablets and associated names

Referral: SGLT2 inhibitors

Referral: Tysabri

Referral: Tobramycin VVB and associated names

Referral: Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard

Referral: Inductos

Referral: Merisone and associated names

Referral: Myoson and associated names

Referral: Iclusig

Referral: Corlentor and Procoralan

Referral: Seasonique and associated names

Referral: Oxynal Targin and associated names

Referral: Protelos and Osseor

Referral: Dexamed and associated names

Referral: Nanotop and associated names

Referral: Kogenate Bayer and Helixate NexGen

Referral: Tibolona Aristo and Tibocina and associated names